Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04995315 · ClinicalTrials.gov registry record
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008
A clinical trial, sponsored by Agios Pharmaceuticals.
- Completed
- Registry status
- 13
- Enrollment target
NCT04995315 is a clinical trial that has completed, run by Agios Pharmaceuticals. The registered enrollment target is 13 participants.
The verdict
NCT04995315 has completed, sponsored by Agios Pharmaceuticals.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This is a substudy of Study AG348-C-008, an observational, longitudinal, multicenter, global registry that aims to better understand the longitudinal clinical implications of pyruvate kinase deficiency (PK deficiency). The primary purpose of this study is to describe the cognition of participants with PK deficiency, as objectively measured by the Cogstate Brief Battery (CBB).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-07-02 |
| Est. Completion | 2023-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04995315
The ClinicalTrials.gov registry entry for NCT04995315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Agios Pharmaceuticals, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04995315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04995315 about?
NCT04995315 is a clinical study titled "Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008". This is a substudy of Study AG348-C-008, an observational, longitudinal, multicenter, global registry that aims to better understand the longitudinal clinical implications of pyruvate kinase deficiency (PK deficiency). The primary purpose of this study is to describe the cognition of participants wi...
What is the current status of trial NCT04995315?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2021-07-02. Estimated completion is 2023-09-22.
Who is sponsoring clinical trial NCT04995315?
This trial is sponsored by Agios Pharmaceuticals, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.